PMC9041751_01
(A) Roadmap of sample collection per tested individuals (B) Quantification of sequences mapping to unique regions in Omicron BA.1 and omicron BA.2 per day. More information can be found in Supplementary Datasheet S2. (C) Phylogenetic tree of genome assemblies.
fgene-13-892682-g001.jpg
PMC9041751_02_fgene-13-892682-g001.jpg
F1
Her partner, a 35-year-old male (individual 2) tested positive at day 1 for trace amounts of SARS-CoV-2, yielding a non-SGTF PCR, which was confirmed by follow-up non-SGTF PCRs at day 2, day 4, day 8, day 11, and Day 14 (Table 1; Supplementary Figure S1). More focused analysis of selected sequences in regions specific for BA.1 and BA.2 revealed the presence of sequences specific for both genomes, with the majority of sequences belonging to BA.1 (Figure 1B; Supplementary Figure S2). Further sequencing at day 4 and day 8 unequivocally identified the BA.2 subvariant with none of the BA.1 specific sequences present in our samples (Figures 1B,C; Supplementary Figure S2).
PMC9041751_02
(A) Roadmap of sample collection per tested individuals (B) Quantification of sequences mapping to unique regions in Omicron BA.1 and omicron BA.2 per day. More information can be found in Supplementary Datasheet S2. (C) Phylogenetic tree of genome assemblies.
fgene-13-892682-g001.jpg
PMC9041751_02_fgene-13-892682-g001.jpg
F1
Her partner, a 35-year-old male (individual 2) tested positive at day 1 for trace amounts of SARS-CoV-2, yielding a non-SGTF PCR, which was confirmed by follow-up non-SGTF PCRs at day 2, day 4, day 8, day 11, and Day 14 (Table 1; Supplementary Figure S1). More focused analysis of selected sequences in regions specific for BA.1 and BA.2 revealed the presence of sequences specific for both genomes, with the majority of sequences belonging to BA.1 (Figure 1B; Supplementary Figure S2). Further sequencing at day 4 and day 8 unequivocally identified the BA.2 subvariant with none of the BA.1 specific sequences present in our samples (Figures 1B,C; Supplementary Figure S2).